13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001841857
Total reported value
$157.4M
$157.4M
64 檔
17.1%
As reported in its official Q3 2024 Form 13F filing, CM Management, LLC's tracked investment portfolio stood at $157.4M with 64 total positions.
During Q3 2024, CM Management, LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including ALCO, TGB, RLGT) accounted for 17.1% of total reported equity market value during Q3 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ALCO | Alico Inc | Stock-Other | 5.02% | -1.64% | — | |
| 2 | TGB | Taseko Mines LTD | Stock-Other | 4.93% | — | — | |
| 3 | RLGT | Radiant Logistics Inc | Stock-Other | 3.98% | -0.10% | — | |
| 4 | AM6 | Amicus Therapeutics Inc | Stock-Other | 3.84% | — | — | |
| 5 | RIGL | Rigel Pharmaceuticals Inc | Stock-Other | 3.74% | +0.90% | — | |
| 6 | NMRK | Newmark Group Inc-class A | Stock-Other | 3.72% | -0.46% | -25.00% | |
| 7 | RPRX | Royalty Pharma plc | Stock-Healthcare | 3.61% | -0.56% | — | |
| 8 | TALO | Talos Energy Inc | Stock-Other | 2.89% | +0.62% | NEW | |
| 9 | PLPC | Preformed Line Products Co | Stock-Other | 2.76% | — | +3.85% | |
| 10 | CLPT | Clearpoint Neuro Inc | Stock-Other | 2.68% | +0.28% | -20.00% | |
| 11 | ARKO | Arko CORP | Stock-Other | 2.60% | +0.05% | — | |
| 12 | KD | Kyndryl Holdings Inc | Stock-Tech | 2.57% | — | — | |
| 13 | PD | Pagerduty Inc | Stock-Other | 2.22% | +0.23% | +25.00% | |
| 14 | INTT | Intest CORP | Stock-Other | 2.04% | -3.77% | EXIT | |
| 15 | BGC | Bgc Group Inc-a | Stock-Financials | 2.01% | -0.62% | -15.38% | |
| 16 | CGAU | Centerra Gold Inc | Stock-Other | 2.00% | — | +16.67% | |
| 17 | ABX | Barrick Gold CORP | Stock-Financials | 1.98% | — | — | |
| 18 | EOLS | Evolus Inc | Stock-Other | 1.94% | +0.39% | — | |
| 19 | ARKR | Ark Restaurants CORP | Stock-Other | 1.91% | -0.39% | — | |
| 20 | SABR | Sabre CORP | Stock-Tech | 1.90% | -0.02% | +8.33% | |
| 21 | IOVA | Iovance Biotherapeutics Inc | Stock-Other | 1.87% | -0.13% | — | |
| 22 | VTRS | Viatris Inc | Stock-Healthcare | 1.85% | -0.21% | — | |
| 23 | RBCAA | Republic Bancorp Inc-class A | Stock-Other | 1.82% | -0.05% | — | |
| 24 | BB3 | Brookline Bancorp Inc | Stock-Other | 1.81% | — | +18.42% | |
| 25 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 1.78% | — | +60.00% | |
| 26 | CVS | Cvs Health CORP | Stock-Healthcare | 1.76% | — | +16.67% | |
| 27 | PK | Park Hotels & Resorts Inc | Stock-Real Estate | 1.69% | -0.39% | +200.00% | |
| 28 | CHRS | Coherus Oncology Inc | Stock-Other | 1.66% | -1.10% | +81.82% | |
| 29 | OGN | Organon & Co | Stock-Healthcare | 1.53% | +0.36% | -20.00% | |
| 30 | THFF | First Financial CORP | Stock-Other | 1.49% | -1.59% | EXIT | |
| 31 | WBA | Walgreens Boots Alliance Inc | Stock-Other | 1.43% | — | +33.33% | |
| 32 | PFE | Pfizer Inc | Stock-Healthcare | 1.39% | +0.31% | NEW | |
| 33 | CPA | Copa Holdings, S.A. | Stock-Other | 1.31% | +0.95% | — | |
| 34 | COHU | Cohu Inc | Stock-Other | 1.23% | — | +100.00% | |
| 35 | FCX | Freeport-mcmoran Inc | Stock-Materials | 1.20% | — | — | |
| 36 | XOMA | Xoma Royalty Corporation | Stock-Other | 1.16% | -1.05% | EXIT | |
| 37 | WBD | Warner Bros Discovery Inc | Stock-Comm Services | 1.15% | — | -12.50% | |
| 38 | SVC | Service Properties Trust | Stock-Other | 1.09% | -0.19% | — | |
| 39 | HRI | Herc Holdings Inc | Stock-Other | 1.02% | +0.54% | — | |
| 40 | DIT | Amcon Distributing Co | Stock-Other | 0.96% | -0.40% | +1.62% | |
| 41 | CTSO | Cytosorbents CORP | Stock-Other | 0.96% | -0.35% | -5.88% | |
| 42 | ACAD | Acadia Pharmaceuticals Inc | Stock-Healthcare | 0.86% | — | +75.00% | |
| 43 | PRGO | Perrigo Company plc | Stock-Healthcare | 0.84% | — | — | |
| 44 | PAAS | Pan American Silver CORP | Stock-Materials | 0.83% | — | -33.33% | |
| 45 | HRTX | Heron Therapeutics Inc | Stock-Other | 0.79% | -0.40% | +66.67% | |
| 46 | NKTREUR | Nektar Therapeutics | Stock-Other | 0.78% | — | — | |
| 47 | BATL | Battalion Oil CORP | Stock-Other | 0.75% | — | — | |
| 48 | COYA | Coya Therapeutics Inc | Stock-Other | 0.74% | +0.25% | +44.06% | |
| 49 | AVIR | Atea Pharmaceuticals Inc | Stock-Other | 0.72% | -0.55% | — | |
| 50 | NWL | Newell Brands Inc | Stock-Consumer Staples | 0.61% | +0.21% | -42.86% |
According to official SEC Form 13F filings, CM Management, LLC reported a total U.S. public equity portfolio value of $157.4M across 64 disclosed positions in Q3 2024.
During Q3 2024, CM Management, LLC's top holdings by market value included ALCO (5.0%)、TGB (4.9%)、RLGT (4.0%). The largest single position, ALCO, represented 5.0% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In Q3 2024, CM Management, LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.